Back to search

Article

Resmetirom Attenuates Atherosclerosis in ApoE ⁻/⁻ Mice by Suppressing the NF- κB/ROS–NLRP3 Inflammasome Axis

2026-02-24

Abstract excerpt

<title>Abstract</title> <p> Atherosclerosis is a chronic inflammatory vascular disease in which the NLRP3 inflammasome and NF-κB signaling play central pathogenic roles. Resmetirom, a liver-selective thyroid hormone receptor β (THR-β) agonist approved for metabolic dysfunction-associated steatohepatitis (MASH), exhibits potent lipid-lowering effects, yet its anti-inflammatory actions in atherosclerosis remain un...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9bdb9d0b-5862-58a1-bf9b-70e18fd72a7b
DOI
10.21203/rs.3.rs-8902352/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Resmetirom Attenuates Atherosclerosis in ApoE ⁻/⁻ Mice by Suppressing the NF- κB/ROS–NLRP3 Inflammasome AxisDOI 10.21203/rs.3.rs-8902352/v1
Select a neighboring publication to make it the new centre.